TriSalus Life Sciences (TLSI) Accounts Payables (2022 - 2025)
Historic Accounts Payables for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $3.8 million.
- TriSalus Life Sciences' Accounts Payables rose 16168.74% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 16168.74%. This contributed to the annual value of $2.3 million for FY2024, which is 3294.01% down from last year.
- As of Q3 2025, TriSalus Life Sciences' Accounts Payables stood at $3.8 million, which was up 16168.74% from $1.9 million recorded in Q2 2025.
- Over the past 5 years, TriSalus Life Sciences' Accounts Payables peaked at $4.9 million during Q4 2022, and registered a low of $765244.0 during Q2 2022.
- For the 4-year period, TriSalus Life Sciences' Accounts Payables averaged around $2.3 million, with its median value being $2.0 million (2024).
- In the last 5 years, TriSalus Life Sciences' Accounts Payables surged by 24893.98% in 2023 and then plummeted by 3294.01% in 2024.
- Over the past 4 years, TriSalus Life Sciences' Accounts Payables (Quarter) stood at $4.9 million in 2022, then plummeted by 31.45% to $3.4 million in 2023, then tumbled by 32.94% to $2.3 million in 2024, then soared by 66.4% to $3.8 million in 2025.
- Its Accounts Payables stands at $3.8 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.8 million for Q1 2025.